相关实验视频
Updated: Jul 29, 2025

08:34
Isolation of Atrial Myocytes from Adult Mice
Published on: July 25, 2019
10.5K
胺H1受体在哺乳动物心脏中的功能和作用
Joachim Neumann1, Britt Hofmann2, Uwe Kirchhefer3
1Institut für Pharmakologie und Toxikologie, Medizinische Fakultät, Magdeburger Straße 4, Martin-Luther-Universität Halle-Wittenberg, 06097 Halle, Germany.
Pharmaceuticals (Basel, Switzerland)
|May 27, 2023
概括
组胺会影响心脏功能,对物种和心脏区域的影响各不相同. 本综述侧重于人们对心脏 histamine H1 受体的了解不足,强调其作为药物点的潜力.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
背景情况:
- 希斯胺影响哺乳动物的心脏收缩和心率,表现出特定于物种和区域的效应.
- 虽然心脏中的基因组H2受体得到了充分的研究,但基因组H1受体的作用仍然不太清楚.
- 基因组胺在哺乳动物心脏内源性地产生,这表明自己克林或对克林功能.
研究的目的:
- 审查心脏组胺H1受体的结构,信号转导和表达调节.
- 识别有关心脏组胺H1受体功能的知识差距和分歧领域.
- 探索心脏组织胺H1受体作为治疗点的潜力.
主要方法:
- 文献综述侧重于哺乳动物心脏中的组胺H1受体.
- 分析关于组胺H1受体结构和信号通路的现有数据.
- 检查基因组胺受体的特定物种和区域的表达模式.
主要成果:
- 组胺H1受体在心肌细胞中表达,但它们的功能意义尚不清楚.
- 在组胺受体表达和功能方面存在显著的物种和区域差异.
- 疾病和某些药物 (抗抑郁药,神经乱药) 可以改变心脏组胺H1受体的表达和活性.
结论:
- 需要进一步的研究来阐明心脏组胺H1受体的精确作用.
- 组胺H1受体代表了新型心血管治疗的潜在目标.
- 了解心脏组胺H1受体的功能可以改善药物的疗效和患者的治疗结果.
相关概念视频
G-Protein Gated Ion Channels
4.6K
GPCRs are primarily responsible for our sense of smell, taste, and vision. The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory...
Sensory...
4.6K
Regulation of Heart Rates
1.9K
The regulation of heart rate is a complex process controlled by the autonomic nervous system (ANS), hormonal influences, and intrinsic cardiac mechanisms. The ANS has two main components: the sympathetic nervous system (SNS) and the parasympathetic nervous system (PNS).
The SNS increases heart rate through the release of norepinephrine and epinephrine, which act on beta-1 adrenergic receptors in the heart. This action increases the rate of depolarization in the sinoatrial (SA) node, the heart's...
The SNS increases heart rate through the release of norepinephrine and epinephrine, which act on beta-1 adrenergic receptors in the heart. This action increases the rate of depolarization in the sinoatrial (SA) node, the heart's...
1.9K
Antihypertensive Drugs: Action of β1 Blockers
494
β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
494
Sympathetic Signaling
1.1K
Sympathetic signaling, a vital part of the autonomic nervous system, plays a crucial role in mobilizing the body's resources in response to stress or emergencies. It involves the transmission of nerve impulses from sympathetic preganglionic fibers to postganglionic fibers. This results in the release of specific neurotransmitters and activation of adrenergic receptors.
Sympathetic preganglionic fibers release the neurotransmitter acetylcholine (ACh) onto the ganglionic neurons in the...
Sympathetic preganglionic fibers release the neurotransmitter acetylcholine (ACh) onto the ganglionic neurons in the...
1.1K
Adrenergic Receptors: ɑ Subtype
1.6K
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
1.6K
Adrenergic Receptors: β Subtype
1.8K
β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
1.8K

